The 2023 annual compensation of Mr. Hingtgen was $8,348,223, and the estimated value of his health and welfare benefits was $22,670, according to the report. The median employee compensation, including the estimated value of health and welfare benefits, was $87,176, making the ratio of these amounts 96:1.
As of Dec. 31, 2023, CHS had about 61,000 employees, according to the report. This figure included full-time, part-time and temporary employees. To identify the median compensated employee, the company used base salary as its consistently applied compensation measure. CHS said because all of its employees are located in the U.S., as is the CEO, it did not make any cost-of-living adjustments.
The SEC requires public companies to disclose how CEO pay stacks up with the median employee’s overall compensation each year.
In 2022, CHS’ CEO-to-worker pay ratio was 97:1, according to that year’s SEC filing.
After Mr. Hingtgen, the highest earners at CHS in 2023 were CFO Kevin Hammons and Chief Medical Officer Lynn Simon, MD, earning $3,750,006 and $2,144,471, respectively.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
